Abnormal Gamma Oscillations in N-Methyl-D-Aspartate Receptor Hypofunction Models of Schizophrenia

Biological Psychiatry

Volumn 79, Issue 9, 2016, Pages 716-726

  Jadi, Monika P ^a,b   Behrens, M Margarita ^a   Sejnowski, Terrence J ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Computational models; Gamma oscillations; Inhibition; NMDA hypofunction; Parvalbumin; Schizophrenia

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; PARVALBUMIN;

BRAIN FUNCTION; CORTICAL DISINHIBITION; EEG ABNORMALITY; ELECTROENCEPHALOGRAPHY; GAMMA RHYTHM; GENETIC MODEL; HUMAN; MAGNETOENCEPHALOGRAPHY; NEUROPHARMACOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; STIMULUS RESPONSE; TASK PERFORMANCE; VISUAL CORTEX; ACTION POTENTIAL; ANIMAL; BIOLOGICAL MODEL; BRAIN CORTEX; GENETICS; INTERNEURON; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACTION POTENTIALS; ANIMALS; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; GABAERGIC NEURONS; GAMMA RHYTHM; GAMMA-AMINOBUTYRIC ACID; HUMANS; INTERNEURONS; MODELS, NEUROLOGICAL; PARVALBUMINS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 85028283006     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.07.005     Document Type: Review

References (116)

1. Lewis, D.A., Hashimoto, T., Volk, D.W., Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6 (2005), 312–324.
2. Uhlhaas, P.J., Singer, W., Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11 (2010), 100–113.
3. Wenk, G.L., Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 64:suppl 9 (2003), 7–10.
4. Akbarian, S., Kim, J.J., Potkin, S.G., Hagman, J.O., Tafazzoli, A., Bunney, W.E. Jr, Jones, E.G., Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52 (1995), 258–266.
5. Volk, D.W., Austin, M.C., Pierri, J.N., Sampson, A.R., Lewis, D.A., Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57 (2000), 237–245.
6. Woo, T.U., Whitehead, R.E., Melchitzky, D.S., Lewis, D.A., A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A 95 (1998), 5341–5346.
7. Beasley, C.L., Reynolds, G.P., Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr Res 24 (1997), 349–355.
8. Singer, W., Gray, C.M., Visual feature integration and the temporal correlation hypothesis. Annu Rev Neurosci 18 (1995), 555–586.
9. Salinas, E., Sejnowski, T.J., Correlated neuronal activity and the flow of neural information. Nat Rev Neurosci 2 (2001), 539–550.
10. Gonzalez-Burgos, G., Lewis, D.A., GABA neurons and the mechanisms of network oscillations: Implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull 34 (2008), 944–961.
11. Uhlhaas, P.J., Singer, W., Neural synchrony in brain disorders: Relevance for cognitive dysfunctions and pathophysiology. Neuron 52 (2006), 155–168.
12. Cho, R.Y., Konecky, R.O., Carter, C.S., Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci U S A 103 (2006), 19878–19883.
13. Haenschel, C., Bittner, R.A., Waltz, J., Haertling, F., Wibral, M., Singer, W., et al. Cortical oscillatory activity is critical for working memory as revealed by deficits in early-onset schizophrenia. J Neurosci 29 (2009), 9481–9489.
14. Minzenberg, M.J., Firl, A.J., Yoon, J.H., Gomes, G.C., Reinking, C., Carter, C.S., Gamma oscillatory power is impaired during cognitive control independent of medication status in first-episode schizophrenia. Neuropsychopharmacology 5 (2010), 2590–2599.
15. Spencer, K.M., Nestor, P.G., Perlmutter, R., Niznikiewicz, M.A., Klump, M.C., Frumin, M., et al. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci U S A 101 (2004), 17288–17293.
16. Lee, S.H., Wynn, J.K., Green, M.F., Kim, H., Lee, K.J., Nam, M., et al. Quantitative EEG and low resolution electromagnetic tomography (LORETA) imaging of patients with persistent auditory hallucinations. Schizophr Res 83 (2006), 111–119.
17. Spencer, K.M., Niznikiewicz, M.A., Nestor, P.G., Shenton, M.E., McCarley, R.W., Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia. BMC Neurosci, 10, 2009, 85.
18. Spencer, K.M., Salisbury, D.F., Shenton, M.E., McCarley, R.W., Gamma-band auditory steady-state responses are impaired in first episode psychosis. Biol Psychiatry 64 (2008), 369–375.
19. Winterer, G., Ziller, M., Dorn, H., Frick, K., Mulert, C., Wuebben, Y., et al. Schizophrenia: Reduced signal-to-noise ratio and impaired phase-locking during information processing. Clin Neurophysiol 111 (2000), 837–849.
20. Spencer, K.M., Baseline gamma power during auditory steady-state stimulation in schizophrenia. Front Hum Neurosci, 5, 2012, 190.
21. Rutter, L., Carver, F.W., Holroyd, T., Nadar, S.R., Mitchell-Francis, J., Apud, J., et al. Magnetoencephalographic gamma power reduction in patients with schizophrenia during resting condition. Hum Brain Mapp 30 (2009), 3254–3264.
22. Uhlhaas, P.J., Singer, W., Neuronal dynamics and neuropsychiatric disorders: Toward a translational paradigm for dysfunctional large-scale networks. Neuron 75 (2012), 963–980.
23. Carlsson, A., Lindqvist, M., Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copeng) 20 (1963), 140–144.
24. Seeman, P., Lee, T., Chau-Wong, M., Wong, K., Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261 (1976), 717–719.
25. Kellendonk, C., Simpson, E.H., Polan, H.J., Malleret, G., Vronskaya, S., Winiger, V., et al. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49 (2006), 603–615.
26. Coyle, J.T., The glutamatergic dysfunction hypothesis for schizophrenia. Harv Rev Psychiatry 3 (1996), 241–253.
27. Deutsch, S.I., Mastropaolo, J., Schwartz, B.L., Rosse, R.B., Morihisa, J.M., A “glutamatergic hypothesis” of schizophrenia. Rationale for pharmacotherapy with glycine. Clin Neuropharmacol 12 (1989), 1–13.
28. Javitt, D.C., Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin Psychiatry 9 (1987), 12–35.
29. Lahti, A.C., Holcomb, H.H., Medoff, D.R., Tamminga, C.A., Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6 (1995), 869–872.
30. Olney, J.W., Farber, N.B., Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52 (1995), 998–1007.
31. Tamminga, C.A., Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 12 (1998), 21–36.
32. Lodge, D., Anis, N.A., Effects of phencyclidine on excitatory amino acid activation of spinal interneurones in the cat. Eur J Pharmacol 77 (1982), 203–204.
33. Krystal, J.H., Karper, L.P., Seibyl, J.P., Freeman, G.K., Delaney, R., Bremner, J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51 (1994), 199–214.
34. Hong, L.E., Summerfelt, A., Buchanan, R.W., O'Donnell, P., Thaker, G.K., Weiler, M.A., Lahti, A.C., Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology 35 (2010), 632–640.
35. Olney, J.W., Farber, N.B., NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 13 (1995), 335–345.
36. Moghaddam, B., Adams, B., Verma, A., Daly, D., Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17 (1997), 2921–2927.
37. Poels, E.M., Kegeles, L.S., Kantrowitz, J.T., Slifstein, M., Javitt, D.C., Lieberman, J.A., et al. Imaging glutamate in schizophrenia: Review of findings and implications for drug discovery. Mol Psychiatry 19 (2014), 20–29.
38. Beneyto, M., Abbott, A., Hashimoto, T., Lewis, D.A., Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. Cereb Cortex 21 (2011), 999–1011.
39. Hashimoto, T., Arion, D., Unger, T., Maldonado-Aviles, J.G., Morris, H.M., Volk, D.W., et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 13 (2008), 147–161.
40. Lewis, D.A., Hashimoto, T., Morris, H.M., Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia. Neurotox Res 14 (2008), 237–248.
41. Morris, H.M., Hashimoto, T., Lewis, D.A., Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cereb Cortex 18 (2008), 1575–1587.
42. Volk, D.W., Matsubara, T., Li, S., Sengupta, E.J., Georgiev, D., Minabe, Y., et al. Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatry 169 (2012), 1082–1091.
43. Woo, T.U., Walsh, J.P., Benes, F.M., Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61 (2004), 649–657.
44. Woo, T.U., Shrestha, K., Lamb, D., Minns, M.M., Benes, F.M., N-methyl-D-aspartate receptor and calbindin-containing neurons in the anterior cingulate cortex in schizophrenia and bipolar disorder. Biol Psychiatry 64 (2008), 803–809.
45. Pratt, J., Winchester, C., Dawson, N., Morris, B., Advancing schizophrenia drug discovery: Optimizing rodent models to bridge the translational gap. Nat Rev Drug Discov 11 (2012), 560–579.
46. Bubenikova-Valesova, V., Horacek, J., Vrajova, M., Hoschl, C., Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 32 (2008), 1014–1023.
47. Cunningham, M.O., Hunt, J., Middleton, S., LeBeau, F.E., Gillies, M.J., Davies, C.H., et al. Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness. J Neurosci 26 (2006), 2767–2776.
48. Roopun, A.K., Cunningham, M.O., Racca, C., Alter, K., Traub, R.D., Whittington, M.A., Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia. Schizophr Bull 34 (2008), 962–973.
49. Kittelberger, K., Hur, E.E., Sazegar, S., Keshavan, V., Kocsis, B., Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: Relevance for the NMDA receptor hypofunction model of schizophrenia. Brain Struct Funct 217 (2012), 395–409.
50. Hakami, T., Jones, N.C., Tolmacheva, E.A., Gaudias, J., Chaumont, J., Salzberg, M., et al. NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness. PLoS One, 4, 2009, e6755.
51. Pinault, D., N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biol Psychiatry 63 (2008), 730–735.
52. Lazarewicz, M.T., Ehrlichman, R.S., Maxwell, C.R., Gandal, M.J., Finkel, L.H., Siegel, S.J., Ketamine modulates theta and gamma oscillations. J Cogn Neurosci 22 (2010), 1452–1464.
53. Leung, L.W., Spectral analysis of hippocampal EEG in the freely moving rat: Effects of centrally active drugs and relations to evoked potentials. Electroencephalogr Clin Neurophysiol 60 (1985), 65–77.
54. Ma, J., Leung, L.S., The supramammillo-septal-hippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats. Psychopharmacology (Berl) 191 (2007), 961–974.
55. Ehrlichman, R.S., Gandal, M.J., Maxwell, C.R., Lazarewicz, M.T., Finkel, L.H., Contreras, D., et al. N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia. Neuroscience 158 (2009), 705–712.
56. Palenicek, T., Fujakova, M., Brunovsky, M., Balikova, M., Horacek, J., Gorman, I., et al. Electroencephalographic spectral and coherence analysis of ketamine in rats: Correlation with behavioral effects and pharmacokinetics. Neuropsychobiology 63 (2011), 202–218.
57. Kulikova, S.P., Tolmacheva, E.A., Anderson, P., Gaudias, J., Adams, B.E., Zheng, T., Pinault, D., Opposite effects of ketamine and deep brain stimulation on rat thalamocortical information processing. Eur J Neurosci 36 (2012), 3407–3419.
58. Wood, J., Kim, Y., Moghaddam, B., Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs. J Neurosci 32 (2012), 3022–3031.
59. Caixeta, F.V., Cornelio, A.M., Scheffer-Teixeira, R., Ribeiro, S., Tort, A.B., Ketamine alters oscillatory coupling in the hippocampus. Sci Rep, 3, 2013, 2348.
60. Molina, L.A., Skelin, I., Gruber, A.J., Acute NMDA receptor antagonism disrupts synchronization of action potential firing in rat prefrontal cortex. PLoS One, 9, 2014, e85842.
61. Carlen, M., Meletis, K., Siegle, J.H., Cardin, J.A., Futai, K., Vierling-Claassen, D., et al. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry 17 (2012), 537–548.
62. Korotkova, T., Fuchs, E.C., Ponomarenko, A., von Engelhardt, J., Monyer, H., NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 68 (2010), 557–569.
63. Nakao, K., Nakazawa, K., Brain state-dependent abnormal LFP activity in the auditory cortex of a schizophrenia mouse model. Front Neurosci, 8, 2014, 168.
64. McNally, J.M., McCarley, R.W., Brown, R.E., Chronic ketamine reduces the peak frequency of gamma oscillations in mouse prefrontal cortex ex vivo. Front Psychiatry, 4, 2013, 106.
65. Buzsáki, G., Chrobak, J.J., Temporal structure in spatially organized neuronal ensembles: A role for interneuronal networks. Curr Opin Neurobiol 5 (1995), 504–510.
66. Buzsaki, G., Wang, X.J., Mechanisms of gamma oscillations. Annu Rev Neurosci 35 (2012), 203–225.
67. Cardin, J.A., Carlén, M., Meletis, K., Knoblich, U., Zhang, F., Deisseroth, K., et al. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 459 (2009), 663–667.
68. Sohal, V.S., Zhang, F., Yizhar, O., Deisseroth, K., Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 459 (2009), 698–702.
69. Hansel, D., Mato, G., Meunier, C., Clustering and slow switching in globally coupled phase oscillators. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 48 (1993), 3470–3477.
70. Borgers, C., Kopell, N., Synchronization in networks of excitatory and inhibitory neurons with sparse, random connectivity. Neural Comput 15 (2003), 509–538.
71. Börgers, C., Epstein, S., Kopell, N.J., Background gamma rhythmicity and attention in cortical local circuits: A computational study. Proc Natl Acad Sci U S A 102 (2005), 7002–7007.
72. Ermentrout, G.B., Kopell, N., Fine structure of neural spiking and synchronization in the presence of conduction delays. Proc Natl Acad Sci U S A 95 (1998), 1259–1264.
73. Vierling-Claassen, D., Siekmeier, P., Stufflebeam, S., Kopell, N., Modeling GABA alterations in schizophrenia: A link between impaired inhibition and altered gamma and beta range auditory entrainment. J Neurophysiol 99 (2008), 2656–2671.
74. Volman, V., Behrens, M.M., Sejnowski, T.J., Downregulation of parvalbumin at cortical GABA synapses reduces network gamma oscillatory activity. J Neurosci 31 (2011), 18137–18148.
75. Spencer, K.M., The functional consequences of cortical circuit abnormalities on gamma oscillations in schizophrenia: Insights from computational modeling. Front Hum Neurosci, 3, 2009, 33.
76. Belforte, J.E., Zsiros, V., Sklar, E.R., Jiang, Z., Yu, G., Li, Y., et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 13 (2010), 76–83.
77. Homayoun, H., Moghaddam, B., NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27 (2007), 11496–11500.
78. Staley, K.J., Neurons skip a beat during fast ripples. Neuron 55 (2007), 828–830.
79. Nikolic, D., Hausler, S., Singer, W., Maass, W., Distributed fading memory for stimulus properties in the primary visual cortex. PLoS Biol, 7, 2009, e1000260.
80. Ray, S., Maunsell, J.H.R., Differences in gamma frequencies across visual cortex restrict their possible use in computation. Neuron 67 (2010), 885–896.
81. Wilson, H.R., Cowan, J.D., Excitatory and inhibitory interactions in localized populations of model neurons. Biophys J 12 (1972), 1–24.
82. Jadi, M.P., Sejnowski, T.J., Cortical oscillations arise from contextual interactions that regulate sparse coding. Proc Natl Acad Sci U S A 111 (2014), 6780–6785.
83. Jadi, M.P., Sejnowski, T.J., Regulating cortical oscillations in an inhibition-stabilized network. Proc IEEE Inst Electr Electron Eng, 2014, 102.
84. Whittington, M.A., Traub, R.D., Jefferys, J.G., Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation. Nature 373 (1995), 612–615.
85. Wang, X.J., Buzsáki, G., Gamma oscillation by synaptic inhibition in a hippocampal interneuronal network model. J Neurosci 16 (1996), 6402–6413.
86. Traub, R.D., Whittington, M.A., Colling, S.B., Buzsaki, G., Jefferys, J.G., Analysis of gamma rhythms in the rat hippocampus in vitro and in vivo. J Physiol 493 (1996), 471–484.
87. Van Vreeswijk, C., Abbott, L.F., Ermentrout, G.B., When inhibition not excitation synchronizes neural firing. J Comput Neurosci 1 (1994), 313–321.
88. Buia, C., Tiesinga, P., Attentional modulation of firing rate and synchrony in a model cortical network. J Comput Neurosci 20 (2006), 247–264.
89. Tiesinga, P., Sejnowski, T.J., Cortical enlightenment: Are attentional gamma oscillations driven by ING or PING?. Neuron 63 (2009), 727–732.
90. Traub, R.D., Kopell, N., Bibbig, A., Buhl, E.H., LeBeau, F.E., Whittington, M.A., Gap junctions between interneuron dendrites can enhance synchrony of gamma oscillations in distributed networks. J Neurosci, 21, 2001, 9478–9486.
91. Fukuda, T., Kosaka, T., Singer, W., Galuske, R.A., Gap junctions among dendrites of cortical GABAergic neurons establish a dense and widespread intercolumnar network. J Neurosci, 26, 2006, 3434–3443.
92. Buhl, D.L., Harris, K.D., Hormuzdi, S.G., Monyer, H., Buzsaki, G., Selective impairment of hippocampal gamma oscillations in connexin-36 knock-out mouse in vivo. J Neurosci 23 (2003), 1013–1018.
93. Brunel, N., Wang, X.-J., What determines the frequency of fast network oscillations with irregular neural discharges? I. Synaptic dynamics and excitation-inhibition balance. J Neurophysiol 90 (2003), 415–430.
94. Geisler, C., Brunel, N., Wang, X.J., Contributions of intrinsic membrane dynamics to fast network oscillations with irregular neuronal discharges. J Neurophysiol 94 (2005), 4344–4361.
95. Fuchs, E.C., Zivkovic, A.R., Cunningham, M.O., Middleton, S., Lebeau, F.E., Bannerman, D.M., et al. Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 53 (2007), 591–604.
96. Tatard-Leitman, V.M., Jutzeler, C.R., Suh, J., Saunders, J.A., Billingslea, E.N., Morita, S., et al. Pyramidal cell selective ablation of N-methyl-D-aspartate receptor 1 causes increase in cellular and network excitability. Biol Psychiatry 77 (2015), 556–568.
97. Pfeffer, C.K., Xue, M., He, M., Huang, Z.J., Scanziani, M., Inhibition of inhibition in visual cortex: The logic of connections between molecularly distinct interneurons. Nat Neurosci 16 (2013), 1068–1076.
98. Pi, H.J., Hangya, B., Kvitsiani, D., Sanders, J.I., Huang, Z.J., Kepecs, A., Cortical interneurons that specialize in disinhibitory control. Nature 503 (2013), 521–524.
99. Fu, Y., Tucciarone, J.M., Espinosa, J.S., Sheng, N., Darcy, D.P., Nicoll, R.A., et al. A cortical circuit for gain control by behavioral state. Cell 156 (2014), 1139–1152.
100. Adesnik, H., Bruns, W., Taniguchi, H., Huang, Z.J., Scanziani, M., A neural circuit for spatial summation in visual cortex. Nature 490 (2012), 226–231.
101. Grunze, H.C., Rainnie, D.G., Hasselmo, M.E., Barkai, E., Hearn, E.F., McCarley, R.W., Greene, R.W., NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci 16 (1996), 2034–2043.
102. Rotaru, D.C., Lewis, D.A., Gonzalez-Burgos, G., The role of glutamatergic inputs onto parvalbumin-positive interneurons: Relevance for schizophrenia. Rev Neurosci 23 (2012), 97–109.
103. Behrens, M.M., Ali, S.S., Dao, D.N., Lucero, J., Shekhtman, G., Quick, K.L., Dugan, L.L., Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318 (2007), 1645–1647.
104. Hashimoto, T., Volk, D.W., Eggan, S.M., Mirnics, K., Pierri, J.N., Sun, Z., et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23 (2003), 6315–6326.
105. Konradi, C., Yang, C.K., Zimmerman, E.I., Lohmann, K.M., Gresch, P., Pantazopoulos, H., et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res 131 (2011), 165–173.
106. Sakai, T., Oshima, A., Nozaki, Y., Ida, I., Haga, C., Akiyama, H., et al. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder. Neuropathology 28 (2008), 143–150.
107. Ali, A.B., Thomson, A.M., Synaptic alpha 5 subunit-containing GABAA receptors mediate IPSPs elicited by dendrite-preferring cells in rat neocortex. Cereb Cortex 18 (2008), 1260–1271.
108. Hiyoshi, T., Kambe, D., Karasawa, J., Chaki, S., Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms. Neuropharmacology 85 (2014), 384–396.
109. Kirli, K.K., Ermentrout, G.B., Cho, R.Y., Computational study of NMDA conductance and cortical oscillations in schizophrenia. Front Comput Neurosci, 8, 2014, 133.
110. Buchanan, K.A., Blackman, A.V., Moreau, A.W., Elgar, D., Costa, R.P., Lalanne, T., et al. Target-specific expression of presynaptic NMDA receptors in neocortical microcircuits. Neuron 75 (2012), 451–466.
111. Xu, H., Jeong, H.Y., Tremblay, R., Rudy, B., Neocortical somatostatin-expressing GABAergic interneurons disinhibit the thalamorecipient layer 4. Neuron 77 (2013), 155–167.
112. Brunel, N., Hakim, V., Sparsely synchronized neuronal oscillations. Chaos, 18, 2008, 015113.
113. Brunel, N., Dynamics of sparsely connected networks of excitatory and inhibitory spiking neurons. J Comput Neurosci 8 (2000), 183–208.
114. Kang, K., Shelley, M., Henrie, J.A., Shapley, R., LFP spectral peaks in V1 cortex: Network resonance and cortico-cortical feedback. J Comput Neurosci 29 (2010), 495–507.
115. Wallace, E., Benayoun, M., van Drongelen, W., Cowan, J.D., Emergent oscillations in networks of stochastic spiking neurons. PLoS One, 6, 2011, e14804.
116. Bressloff, P.C., Metastable states and quasicycles in a stochastic Wilson-Cowan model of neuronal population dynamics. Phys Rev E Stat Nonlin Soft Matter Phys, 82, 2010, 051903.